EUVIMEDEUVIMED entdecken
Crossref

Disrupting the Base Excision Repair (BER) Pathway by Targeting the Abasic Site Enhances the Sensitivity of PARP Inhibitor in HR-Proficient Cancer Cells

Achyut Bora iD, Bhim Majhi iD, Subhadeep Palit, Rounak Patra, Sanjay Dutta iD

ACS Chemical Biology · 15.08.2025 · 20 (8) · 1863-1874

DOI: 10.1021/acschembio.5c00022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 21.07.2025. Verfasst von Achyut Bora und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nucleic Acids Research Laboratory, Organic and Medicinal Chemistry Division, CSIR- Indian Institute of Chemical Biology 4, Raja S.C. Mullick Road, Ko…. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, DNA Repair, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Science and Engineering Research Board, CSIR ? Indian Institute of Chemical Biology, CSIR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPis) are clinically effective in homologous recombination (HR)-deficient cancers but have limited efficacy in HR-proficient cancers; therefore, new strategies are needed to address this therapeutic limitation. Since PARP1 recognizes abasic sites as intermediates to repair single-strand breaks (SSBs) in the base excision repair (BER) pathway, we demonstrate that targeting these DNA abasic sites with a fused-quinoxaline-diazepine amine derivative (BA-6) can enhance the effectiveness of the PARPi Olaparib in HR-proficient cancer cells (MDA-MB-231, HeLa, and SKOV3). BA-6 cleaves abasic sites via β- and β,δ-elimination mechanisms, generating unusable substrates for DNA polymerase β, such as 3'-α,β-unsaturated aldehyde and 3'-phosphate products, thereby disrupting the BER pathway and leading to the accumulation of SSBs. Upon combination with a low micromolar dosage of Olaparib, BA-6 exhibited potent synergistic effects in HR-proficient cancer cells by reducing cell viability and clonogenic survival. Interestingly, the following synergy is attributed to PARP trapping at BA-6-induced SSBs, leading to DNA double-strand breaks (DSBs) during replication, as evidenced by an increased comet tail length and γH2AX expression, ultimately inducing S-phase arrest and apoptosis in HR-proficient cancer cells. Furthermore, combining BA-6 with alkylating agents like Temozolomide (TMZ) and methylmethanesulfonate (MMS), which elevate abasic sites, remarkably increased the Olaparib potency (∼55-fold) in HR-proficient cancer cells. Overall, this study established that targeting DNA abasic sites with diazepine hybrids such as BA-6, in combination with known PARPi, acts as a rational strategy to enhance the therapeutic efficacy even in HR-proficient cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsDNA RepairAntineoplastic AgentsNeoplasmsHumansPhthalazinesCell Line, TumorPiperazinesHomologous RecombinationQuinoxalinesExcision Repair

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPhthalazinesolaparibPiperazinesAntineoplastic AgentsQuinoxalines

Autor:innen und Institutionen

  • Nucleic Acids Research Laboratory, Organic and Medicinal Chemistry Division, CSIR- Indian Institute of Chemical Biology 4, Raja S.C. Mullick Road, Kolkata 700032, West Bengal, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

ORCID-Profile: Achyut Bora, Bhim Majhi, Sanjay Dutta

Förderung

  • Science and Engineering Research Board
  • CSIR ? Indian Institute of Chemical Biology
  • CSIR

Zitieren

APA

Bora, A., Majhi, B., Palit, S., Patra, R., & Dutta, S. (2025). Disrupting the Base Excision Repair (BER) Pathway by Targeting the Abasic Site Enhances the Sensitivity of PARP Inhibitor in HR-Proficient Cancer Cells. ACS Chemical Biology, 20(8), 1863-1874. https://doi.org/10.1021/acschembio.5c00022

Vancouver

Bora A, Majhi B, Palit S, Patra R, Dutta S. Disrupting the Base Excision Repair (BER) Pathway by Targeting the Abasic Site Enhances the Sensitivity of PARP Inhibitor in HR-Proficient Cancer Cells. ACS Chemical Biology. 2025;20(8):1863-1874. doi:10.1021/acschembio.5c00022

BibTeX
@article{Bora2025,
  author = {Bora, Achyut and Majhi, Bhim and Palit, Subhadeep and Patra, Rounak and Dutta, Sanjay},
  title = {Disrupting the Base Excision Repair (BER) Pathway by Targeting the Abasic Site Enhances the Sensitivity of PARP Inhibitor in HR-Proficient Cancer Cells},
  journal = {ACS Chemical Biology},
  year = {2025},
  volume = {20},
  number = {8},
  pages = {1863--1874},
  doi = {10.1021/acschembio.5c00022}
}
Kostenlos starten →